Quantitative analyses of immunohistochemistry (IHC) staining indicated that GOLPH3 levels increased in colon cancer tissue as the clinical-stage advanced and were elevated overall compared with the levels in normal tissue (Fig. 1C, D). This evidence concerns the gene GOLPH3 and malignant colon neoplasm.